 |
| Research Antibodies Market |
Research antibodies are glycoproteins used in various biomedical research, clinical diagnostics and drug discovery processes. They exhibit high affinity and specificity in binding to antigens, which are beneficial in performing various diagnostic tests, identifying biomarkers and target proteins for effective treatments. The growing demand for disease diagnosis and development of targeted therapeutics are driving the adoption of research antibodies. The global Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of personalized medicine has accelerated the growth of
the research antibodies market over the forecast period. Personalized medicine
relies on genetic and molecular profiling to classify individuals based on
their susceptibility, prognosis, and potential response to therapeutic drugs.
It enables the development of targeted therapies as per individual patient's
genetic makeup. Research antibodies play a critical role in biomarker
discovery, which enables a tailored treatment approach for improved clinical
outcomes. This growing focus on targeted therapeutics over conventional drugs
is expected to drive the demand for research antibodies during the forecast
period.
Segment Analysis
The global research antibodies market is dominated by catalog antibodies
segment. Catalog antibodies refers to the pre-made antibodies which are
available off the shelf and hence are preferred by majority of researchers over
custom antibodies. Catalog antibodies facilitate ease of use as compared to
custom antibodies which need to be tailor made for research projects.
Availability of a large variety of high quality catalog antibodies at
affordable prices is ensuring the growth of this segment.
Key Takeaways
The global Research
Antibodies Market Share is expected to witness high growth. Regional
analysis related content comprises North America currently dominates the
research antibodies market owing to presence of large pharmaceutical companies
undertaking research as well as availability of funding for research. The Asia
Pacific region is expected to grow at the fastest pace owing to increasing
investments in research activities as well as focus of global market players to
tap the opportunities in the region.
Key players related content comprises Key players operating in the research
antibodies market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza
Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche
Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher
Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc.
For more insights, read- https://www.ukwebwire.com/research-antibodies-market-trends-size-and-share-analysis/
0 Comments